[Long-acting fibrinolytic drugs. Drugs acting on platelet aggregation].
D000085:Acetates / Q000627:therapeutic use; D000818:Animals; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001791:Blood Platelet Disorders / Q000188:drug therapy*; D001792:Blood Platelets / Q000187:drug effects; D003692:Delayed-Action Preparations / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009526:Nialamide / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010973:Platelet Adhesiveness / Q000187:drug effects; D011725:Pyridines / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D000085:Acetates; D003692:Delayed-Action Preparations; D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D011725:Pyridines; D013806:Theophylline; D009526:Nialamide
Médications fibrinolytiques de longue durée. Médications actives sur l'agrégation des plaquettes.